TMO vs WT · P/E 24, rev $44.56B vs P/E 44, rev $427.7M
Thermo Fisher Scientific Inc (TMO) versus WisdomTree Inc. (WT) — a side-by-side from cached financials, not a winner call.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
WisdomTree Inc. (WT) is a asset management company listed on NYSE.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Latest reported WT revenue for 2024-12-31 was $427.7M. Net income was $66.7M. Revenue was up 22.5% from 2023-12-31 to 2024-12-31. WT currently screens at market cap $2.78B and trailing P/E 44.3.
TMO currently screens at market cap $153.06B and trailing P/E 23.8. WT currently screens at market cap $2.78B and trailing P/E 44.3.
Not investment advice. Open the TMO and WT stock pages for the full models.
Not investment advice.